News

News
Partner news

BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders

Read full story
Partner news

Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen

Read full story
Partner news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story
Partner news

Memebox Closes $35 Million Financing to Fuel Innovation and Accelerate Company Growth

Read full story
Partner news

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Read full story
Other news

Johnson & Johnson Innovation Awards Bloomlife the First 1000 Days QuickFire Challenge

Read full story
Partner news

Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

Read full story
Other news

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

Read full story
Partner news

E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer

Read full story
Partner news

Carbon Announces JJDC as Additional Investor in $200 Million Funding Round

Read full story
Partner news

Nuevolution to receive license fee payment of USD 750,000

Read full story
Partner news

Alligator Bioscience to Receive USD 6 Million Milestone Payment from Janssen Coupled to the Decision to Initiate Combination Trial with ADC-1013

Read full story
Partner news

Verb Surgical Delivers Digital Surgery Prototype Demonstration to Collaboration Partners

Read full story
Partner news

BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing

Read full story
Partner news

Inivata Completes £31.5 Million ($45M) Series A Fundraising Round

Read full story